TILAVONEMAB

UNII:	MY9Z7GDJ8J
Formula:
Preferred Substance Name:	TILAVONEMAB

2096513-89-0
ABBV-8E12
C2N8E12
C2N-8E12
IMMUNOGLOBULIN G4, ANTI-(HUMAN TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1649264 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1649264 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE-ASSOCIATED PROTEIN TAU, TAU)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-442) (VH (MUS MUSCULUS IGHV6-3*01 (91.9%)-(IGHD)-IGHJ4*01 (92.3%)/HOMO SAPIENS IGHV3-7*01 (71.4%)-(IGHD)-IGHJ4*01 (92.3%)) (8.10.6) (1-115)-HOMO SAPIENS IGHG4*01 (CH1 (116-213), HINGE S10>P (223) (214-225), CH2 (226-335), CH3 (336-440), CHS (441-442)) (115-442)), (129-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-7*01 (90.9%)-IGKJ2*03 (90.9%)/HOMO SAPIENS IGKV4-1*01 (69.3%)-IGKJ2*01 (100%)) (10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218'))DIMER (221-221'':224-224'')-BISDISULFIDE
TILAVONEMAB [INN]
TILAVONEMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TILAVONEMAB

Synonyms and Mappings

Resources